Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew F Mescher

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2013
Cutting edge: IL-12 and type I IFN differentially program CD8 T cells for programmed death 1 re-expression levels and tumor controlMichael Y Gerner, Lynn M Heltemes-Harris, Brian T Fife, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
Programming for CD8 T cell memory development requires IL-12 or type I IFNZhengguo Xiao, Kerry A Casey, Stephen C Jameson, et al.
Seminars in Cancer Biology|July 28, 2007
Activation-induced non-responsiveness (anergy) limits CD8 T cell responses to tumorsMatthew F Mescher, Flavia E Popescu, Michael Gerner, et al.
Seminars in Immunology|March 27, 2007
Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activationMatthew F Mescher, Pujya Agarwal, Kerry A Casey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Phase I trial of large multivalent immunogen derived from melanoma lysates in patients with disseminated melanomaMalcolm S Mitchell, June Kan-Mitchell, Philip R Morrow, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
CD4 T cell-dependent conditioning of dendritic cells to produce IL-12 results in CD8-mediated graft rejection and avoidance of toleranceAlexander A Filatenkov, Erica L Jacovetty, Ursula B Fischer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 14, 2009
Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memoryPujya Agarwal, Arvind Raghavan, Sarada L Nandiwada, et al.
American Journal of Clinical Oncology|April 9, 2008
Autologous large multivalent immunogen vaccine in patients with metastatic melanoma and renal cell carcinomaArkadiusz Z Dudek, Matthew F Mescher, Ian Okazaki, et al.
Immunological Reviews|July 11, 2006
Signals required for programming effector and memory development by CD8+ T cellsMatthew F Mescher, Julie M Curtsinger, Pujya Agarwal, et al.
Blood|March 20, 2004
Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-specific cytotoxic T lymphocytesLiesbeth E M Oosten, Els Blokland, Astrid G S van Halteren, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2013
Cutting edge: IL-12 and type I IFN differentially program CD8 T cells for programmed death 1 re-expression levels and tumor controlMichael Y Gerner, Lynn M Heltemes-Harris, Brian T Fife, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
Programming for CD8 T cell memory development requires IL-12 or type I IFNZhengguo Xiao, Kerry A Casey, Stephen C Jameson, et al.
Seminars in Cancer Biology|July 28, 2007
Activation-induced non-responsiveness (anergy) limits CD8 T cell responses to tumorsMatthew F Mescher, Flavia E Popescu, Michael Gerner, et al.
Seminars in Immunology|March 27, 2007
Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activationMatthew F Mescher, Pujya Agarwal, Kerry A Casey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Phase I trial of large multivalent immunogen derived from melanoma lysates in patients with disseminated melanomaMalcolm S Mitchell, June Kan-Mitchell, Philip R Morrow, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
CD4 T cell-dependent conditioning of dendritic cells to produce IL-12 results in CD8-mediated graft rejection and avoidance of toleranceAlexander A Filatenkov, Erica L Jacovetty, Ursula B Fischer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 14, 2009
Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memoryPujya Agarwal, Arvind Raghavan, Sarada L Nandiwada, et al.
American Journal of Clinical Oncology|April 9, 2008
Autologous large multivalent immunogen vaccine in patients with metastatic melanoma and renal cell carcinomaArkadiusz Z Dudek, Matthew F Mescher, Ian Okazaki, et al.
Immunological Reviews|July 11, 2006
Signals required for programming effector and memory development by CD8+ T cellsMatthew F Mescher, Julie M Curtsinger, Pujya Agarwal, et al.
Blood|March 20, 2004
Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-specific cytotoxic T lymphocytesLiesbeth E M Oosten, Els Blokland, Astrid G S van Halteren, et al.
Pageof 4